GT Biopharma, Inc. Quarterly Weighted Average Number of Shares Outstanding, Diluted from Q1 2012 to Q3 2024
-
Taxonomy & unit
-
us-gaap: shares
-
Description
-
The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.
-
Summary
-
GT Biopharma, Inc. quarterly/annual Weighted Average Number of Shares Outstanding, Diluted history and growth rate from Q1 2012 to Q3 2024.
- GT Biopharma, Inc. Weighted Average Number of Shares Outstanding, Diluted for the quarter ending September 30, 2024 was 2.23M shares, a 63.4% increase year-over-year.
- GT Biopharma, Inc. annual Weighted Average Number of Shares Outstanding, Diluted for 2023 was 1.35M shares, a 26.9% increase from 2022.
- GT Biopharma, Inc. annual Weighted Average Number of Shares Outstanding, Diluted for 2022 was 1.06M shares.
- GT Biopharma, Inc. annual Weighted Average Number of Shares Outstanding, Diluted for 2020 was 4.39M shares, a 29.6% increase from 2019.
Weighted Average Number of Shares Outstanding, Diluted, Quarterly (shares)
Weighted Average Number of Shares Outstanding, Diluted, YoY Quarterly Growth (%)